Found: 53
Select item for more details and to access through your institution.
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM)
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 9, p. 1, doi. 10.1007/s00520-024-08786-8
- By:
- Publication type:
- Article
Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 3393, doi. 10.2147/PPA.S381812
- By:
- Publication type:
- Article
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 353, doi. 10.2147/PPA.S351771
- By:
- Publication type:
- Article
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12319-1
- By:
- Publication type:
- Article
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345185, doi. 10.1001/jamanetworkopen.2023.45185
- By:
- Publication type:
- Article
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682449
- By:
- Publication type:
- Article
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.626104
- By:
- Publication type:
- Article
Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00828
- By:
- Publication type:
- Article
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1361010
- By:
- Publication type:
- Article
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1096, doi. 10.3390/ijms24021096
- By:
- Publication type:
- Article
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
- Published in:
- Clinical & Experimental Metastasis, 2024, v. 41, n. 2, p. 117, doi. 10.1007/s10585-024-10266-6
- By:
- Publication type:
- Article
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
Patient-Factors Influencing the 2-Year Trajectory of Mental and Physical Health in Prostate Cancer Patients.
- Published in:
- Current Oncology, 2022, v. 29, n. 11, p. 8244, doi. 10.3390/curroncol29110651
- By:
- Publication type:
- Article
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7745, doi. 10.3390/curroncol29100612
- By:
- Publication type:
- Article
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4578, doi. 10.3390/curroncol29070362
- By:
- Publication type:
- Article
A novel immunotherapy prognostic score for patients with pretreated advanced urinary Tract Carcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
- Published in:
- Minerva Urology & Nephrology, 2023, v. 75, n. 3, p. 308, doi. 10.23736/S2724-6051.22.05135-7
- By:
- Publication type:
- Article
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
- Published in:
- Minerva Urology & Nephrology, 2022, v. 74, n. 1, p. 11, doi. 10.23736/S2724-6051.20.04032-1
- By:
- Publication type:
- Article
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 12, p. 1605, doi. 10.1093/jnci/djad155
- By:
- Publication type:
- Article
Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2016, v. 6, p. 1, doi. 10.3389/fonc.2016.00253
- By:
- Publication type:
- Article
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01140-9
- By:
- Publication type:
- Article
Renal cell carcinoma: the population, real world, and cost-of-illness.
- Published in:
- BMC Urology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12894-022-01160-y
- By:
- Publication type:
- Article
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
- Published in:
- Familial Cancer, 2015, v. 14, n. 2, p. 309, doi. 10.1007/s10689-014-9771-y
- By:
- Publication type:
- Article
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. e949, doi. 10.1093/oncolo/oyac147
- By:
- Publication type:
- Article
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 740, doi. 10.1002/onco.13842
- By:
- Publication type:
- Article
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease‐19 Pandemic: A Survey of International Expertise Centers.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1509, doi. 10.1634/theoncologist.2020-0420
- By:
- Publication type:
- Article
Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1183749
- By:
- Publication type:
- Article
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211022261
- By:
- Publication type:
- Article
Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211022261
- By:
- Publication type:
- Article
Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/11795549211022261
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 679, doi. 10.1007/s00432-015-2065-4
- By:
- Publication type:
- Article
What do cancer patients experience of the simultaneous care clinic? Results of a cross‐sectional study on patient care satisfaction.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7000
- By:
- Publication type:
- Article
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00553
- By:
- Publication type:
- Article
Prostate cancer imaging: when the game gets tough, the hard one gets done!
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2032, doi. 10.1007/s00259-018-4092-2
- By:
- Publication type:
- Article
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03741-2
- By:
- Publication type:
- Article
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
- By:
- Publication type:
- Article
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
- By:
- Publication type:
- Article
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102444
- By:
- Publication type:
- Article
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.955501
- By:
- Publication type:
- Article
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.918413
- By:
- Publication type:
- Article
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.787835
- By:
- Publication type:
- Article
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4353, doi. 10.3390/cancers15174353
- By:
- Publication type:
- Article
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2394, doi. 10.3390/cancers15082394
- By:
- Publication type:
- Article
Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2568, doi. 10.3390/cancers14102568
- By:
- Publication type:
- Article
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 7, p. 1, doi. 10.1007/s00520-023-07867-4
- By:
- Publication type:
- Article
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53581-4
- By:
- Publication type:
- Article